JJ
EU reportedly in talks with J&J to secure doses of its COVID-19 vaccine
June 19, 2020Medical Communications, Research and Development, Sales and Marketing COVID-19, EU, Europe, J&J, JJ, Vaccine
It has been reported that the European Union is currently negotiating a deal with pharma giant Johnson & Johnson to …
Jury orders Johnson & Johnson to pay $750 million in latest baby powder case
February 7, 2020Medical Communications J&J, JJ, Johnson & Johnson, ovarian cancer, talc, talc powder
Johnson & Johnson have been ordered to pay by a jury $750 million to four plaintiffs over the company’s baby …
Johnson & Johnson CEO testifies for the first time in Baby Powder Cancer trial
January 28, 2020Manufacturing and Production J&J, JJ, Johnson & Johnson, Talc Powder Cancer, baby powder, talc powder
Johnson & Johnson CEO Alex Gorsky faced questions around stock sales and his knowledge of asbestos in the company’s baby …
J&J’s CAR-T candidate boasts 100% response rate in relapsed or refractory multiple myeloma
December 9, 2019Research and Development, Sales and Marketing ASH 2019, CAR-T, J&J, JJ, Johnson & Johnson, pharma
Johnson & Johnson were present at the American Society of Hematology (ASH) Annual Meeting over the weekend to unveil new …
J&J must pay $572 million for fuelling opioid crisis in Oklahoma, judge says
August 27, 2019Manufacturing and Production J&J, JJ, Johnson & Johnson, Oklahoma, opioid crisis, opioids, pharma
A judge in Oklahoma has said that Johnson & Johnson must pay $572 million for the part it played in …
Oklahoma lawyers say J&J is kingpin of pharmaceutical cartel
July 16, 2019Manufacturing and Production J&J, JJ, Oklahoma, opioid crisis, opioids, pharma
Lawyers representing the State of Oklahoma described Johnson & Johnson as the ‘kingpin’ in a ‘pharmaceutical cartel’ as they accused …
Top Ten most popular articles on Pharmafile.com this week!
June 14, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Astellas, GSK, J&J, JJ, Otsuka, Pfizer, Purdue, Sanofi, Vertex, pharma
Pfizer supressed research showing their arthritis drug Enbrel reduced the risk of Alzheimer’s. This was the big revelation this week! …
J&J and Colgate pay $4.8 million each to woman in California
June 13, 2019Business Services, Medical Communications Cancer, J&J, JJ, lawsuit, pharma, talc
A California court has said Johnson & Johnson and Colgate-Palmolive must pay a total of nearly $10 million to a …
J&J ‘worse’ than Purdue Pharma expert witness says
June 12, 2019Research and Development J&J, JJ, Johnson & Johnson, Oklahoma, opioid crisis, phamra
The role Johnson & Johnson played in the opioid crisis was ‘in some ways worse’ than that of Purdue Pharma, …
Healthcare would be ‘on the table’ in post-Brexit trade negotiations with US, Trump’s ambassador says
June 3, 2019Sales and Marketing J&J, JJ, NHS, UK, US, brexit, healthcare
The American Ambassador to the United Kingdom has said that Britain’s healthcare system would be ‘on the table’ in post-Brexit …
Oklahoma prosecutors say J&J used ‘brainwashing campaign’ to boost opioid sales
May 30, 2019Research and Development J&J, JJ, opioid crisis, opioids, pharma, public health
Oklahoma state prosecutors have accused Johnson & Johnson of engaging in a “cynical, deceitful, multibillion-dollar brainwashing campaign” to boost sales …
Top Ten most popular articles on Pharmafile.com this week
May 24, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amgen, Gilead, J&J, JJ, MSD, Sandoz, pharma, top ten
On the day that UK Prime Minister Theresa May announces her resignation, we look back on the week’s biggest stories …
Top Ten most popular articles on Pharmafile.com this week!
May 17, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BMS, Gilead, J&J, JJ, Janssen, Mundipharma, Novartis, Teva, generics
Some big names – including Gilead, Janssen, Teva and Bristol-Myers Squibb – were in trouble this week after two separate …
J&J to invest €100 million into Limerick manufacturing facilities creating 100 new jobs
May 16, 2019Manufacturing and Production Ireland, J&J, JJ, Limerick, medical technology, pharma
Healthcare conglomerate Johnson & Johnson has said it will be investing €100 million into the expansion of its Vision Care …
Top Ten most popular articles on Pharmafile.com this week!
April 26, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Aduro Biotech, Cancer, GSK, ICR, J&J, JJ, Novartis, Sandoz, pharma
The Institute for Cancer Research (ICR) called for new measures to increase the speed with which patients in the UK …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
